GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 85 filers reported holding GALENA BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $47,000 | -89.6% | 135,018 | -86.0% | 0.00% | -80.0% |
Q2 2016 | $450,000 | -77.3% | 966,068 | -28.3% | 0.01% | -78.3% |
Q4 2015 | $1,980,000 | -0.8% | 1,346,904 | +6.7% | 0.02% | -17.9% |
Q3 2015 | $1,995,000 | +69.1% | 1,262,714 | +81.9% | 0.03% | +64.7% |
Q2 2015 | $1,180,000 | +203.3% | 694,333 | +148.2% | 0.02% | +183.3% |
Q1 2015 | $389,000 | -43.9% | 279,700 | -39.1% | 0.01% | -40.0% |
Q4 2014 | $693,000 | -37.6% | 458,952 | -14.9% | 0.01% | -41.2% |
Q3 2014 | $1,110,000 | -13.3% | 539,031 | +28.8% | 0.02% | -15.0% |
Q2 2014 | $1,281,000 | -6.2% | 418,628 | -23.3% | 0.02% | -13.0% |
Q1 2014 | $1,365,000 | – | 545,826 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EQUITEC SPECIALISTS, LLC | 314,900 | $147,000 | 0.03% |
EQUITEC SPECIALISTS, LLC | 120,300 | $56,000 | 0.01% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 39,000 | $18,000 | 0.01% |
Alyeska Investment Group, L.P. | 1,593,277 | $743,000 | 0.01% |
Aspen Investment Management Inc | 15,000 | $7,000 | 0.01% |
GROUP ONE TRADING, L.P. | 966,068 | $450,000 | 0.01% |
Acrospire Investment Management LLC | 11,300 | $5,000 | 0.00% |
SABBY MANAGEMENT, LLC | 113,530 | $53,000 | 0.00% |
COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $5,000 | 0.00% |
ACG Wealth | 25,000 | $12,000 | 0.00% |